Article
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
The Australian and New Zealand journal of psychiatry - 1 Mar 2020
Sarris Jerome, Byrne Gerard J, Bousman Chad A, Cribb Lachlan, Savage Karen M, Holmes Oliver, Murphy Jenifer, Macdonald Patricia, Short Anika, Nazareth Sonia, Jennings Emma, Thomas Stuart R, Ogden Edward, Chamoli Suneel, Scholey Andrew, Stough Con
Abstract excerpt
OBJECTIVE: Previous randomised, double-blind, placebo-controlled studies have shown that Kava (a South Pacific medicinal plant) reduced anxiety during short-term administration. The objective of this randomised, double-blind, placebo-controlled study was to perform a larger, longer-term trial assessing the efficacy and safety of Kava in the treatment of generalised anxiety disorder and to determine whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.